Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Fox

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1983
Paramagnetic centers in the nickel-containing, deazaflavin-reducing hydrogenase from Methanobacterium thermoautotrophicumN Kojima, J A Fox, R P Hausinger, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeysJ A Fox, T E Hotaling, C Struble, et al.
Visual Neuroscience|November 1, 1996
Differentiation of VEP intermodulation and second harmonic components by dichoptic, monocular, and binocular stimulationS Suter, P S Suter, D T Perrier, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safetyS K Kelley, L A Harris, D Xie, et al.
Peptides|September 1, 1989
Neuropeptide-hydrolysing activities in synaptosomal fractions from dog ileum myenteric, deep muscular and submucous plexi. Their participation in neurotensin inactivationH Barelli, S Ahmad, P Kostka, et al.
Seminars in Oncology|September 11, 1999
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)M X Sliwkowski, J A Lofgren, G D Lewis, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 30, 2016
Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometryC M Nijenhuis, L Lucas, H Rosing, et al.
International Journal of Obstetric Anesthesia|February 17, 2015
Emergent transesophageal echocardiography in hemodynamically unstable obstetric patientsP S Burrage, S K Shernan, L C Tsen, et al.
Bulletin of the World Health Organization|January 5, 2005
Variation in the costs of delivering routine immunization services in PeruD Walker, N R Mosqueira, M E Penny, et al.
European Journal of Biochemistry|July 15, 1987
Peptidases in dog-ileum circular and longitudinal smooth-muscle plasma membranes. Their relative contribution to the metabolism of neurotensinF Checler, S Ahmad, P Kostka, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1983
Paramagnetic centers in the nickel-containing, deazaflavin-reducing hydrogenase from Methanobacterium thermoautotrophicumN Kojima, J A Fox, R P Hausinger, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeysJ A Fox, T E Hotaling, C Struble, et al.
Visual Neuroscience|November 1, 1996
Differentiation of VEP intermodulation and second harmonic components by dichoptic, monocular, and binocular stimulationS Suter, P S Suter, D T Perrier, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2001
Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safetyS K Kelley, L A Harris, D Xie, et al.
Peptides|September 1, 1989
Neuropeptide-hydrolysing activities in synaptosomal fractions from dog ileum myenteric, deep muscular and submucous plexi. Their participation in neurotensin inactivationH Barelli, S Ahmad, P Kostka, et al.
Seminars in Oncology|September 11, 1999
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)M X Sliwkowski, J A Lofgren, G D Lewis, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 30, 2016
Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometryC M Nijenhuis, L Lucas, H Rosing, et al.
International Journal of Obstetric Anesthesia|February 17, 2015
Emergent transesophageal echocardiography in hemodynamically unstable obstetric patientsP S Burrage, S K Shernan, L C Tsen, et al.
Bulletin of the World Health Organization|January 5, 2005
Variation in the costs of delivering routine immunization services in PeruD Walker, N R Mosqueira, M E Penny, et al.
European Journal of Biochemistry|July 15, 1987
Peptidases in dog-ileum circular and longitudinal smooth-muscle plasma membranes. Their relative contribution to the metabolism of neurotensinF Checler, S Ahmad, P Kostka, et al.
Pageof 14